You are here

Article Text

Article menu

Download PDFPDF

UpFront
Highlights from this issue
Free
  1. Anton V Emmanuel
  1. Physiology Unit, University College Hospital, , London , , UK

https://doi.org/10.1136/flgastro-2017-100860

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Following the Endoscopy special edition to coincide with Endolive 2017, this edition of Frontline Gastroenterology sees us return to mixed content, spanning service assessments in pancreato-biliary practice, patient education exercises in hepatology and guideline development in paediatric gastroenterology. As articles published in the journal are now cited on PubMed we have seen an increase in submissions, and unfortunately therefore a reduction in acceptance rate. The intention of the editorial team is to keep the journal strong in the domain of publishing articles with direct clinical impact for the specialist and trainee, and we continue to look forward to submissions with that theme.

    The introduction of vedolizumab: pragmatic data from two centres

    The advent of a new therapy for chronic inflammatory bowel disease represents an important milestone in practice for the clinician. And while large scale international randomised clinical trials provide regulators with evidence to licence these medications, local access to formulary often requires country-specific data. As such we are delighted to include in this edition of Frontline Gastroenterology a manuscript on …

    View Full Text